Website designed by: Vanmala VONGKINGKEO
First CARDIATEAM Scientific Exchange Meeting organised
The CARDIATEAM consortium organised with the help of Prof Giuseppe Matullo from Partner 12, the University of Turino, its first Scientific Exchange Meeting on 22nd of April 2021.
The topic of this first Scientific Exchange in a virtual format (due to the ongoing pandemic situation) was on “Omics investigation in the frame of the CARDIATEAM consortium”. The talks were given by the members of the CARDIATEAM consortium on the latest results on the use of omics in the cardiovascular field:
1. Giuseppe Matullo form Partner 12 University of Turin (Italy) : Introduction to genomics and epigenomics investigations in cardiometabolic diseases
2. Flora Sam from Partner 21 Lilly (USA): The transcriptome in cardiometabolic phenotypes – insights for diabetic cardiomyopathy and heart failure?
3. Rui Wang-Sattler from Partner 13 Helmholtz Forschungszentrum (Germany): Identification and validation of candidate biomarkers of metabolic diseases (pre-diabetes, T2D, MI, CKD) by metabolomics.
The talks were then followed by fruitful discussions on the use of Omics to deep-phenotype the patients recruited prospectively in the CARDIATEAM clinical study of the project.
The Omic strategies will be part of the topics discussed during the upcoming Scientific Advisory Board meeting scheduled in the 2nd of July 2021.
First patient in CARDIATEAM study enrolled
Our CARDIATEAM study was initially thought to start in March 2020 but had then been hit as the rest of the world by the COVID pandemic and its measures which were particularly affecting all clinical activities, impacting on the start of our study.
We now have the immense pleasure to announce that on Friday 2nd of October 2020 we were able to include our first patient for the CARDIATEAM study! The patient has been recruited at the Mondor APHP Hospital in Creteil and went through all scheduled exams.
The other participating recruitment centers have already scheduled patient visits in the coming weeks, so the study is officially kicked off now.
CARDIATEAM webinar for imaging
With the aim to instruct the teams of the clinical centers who will participate to the CARDIATEAM study, a webinar had been organised at the end of November 2019.
Prof Genevieve DERUMEAUX (Inserm), Prof. Javier BERMEJO (CIBER) , Prof Alban REDHEUIL (APHP) and Prof. Jan D’HOOGE (KU Leuven) gave lectures on the different imaging aspects of the study.
Consortium meeting: 2-3 April 2020! - POSTPONED
Due to the COVID -19 situation the project decided to postpone to a later date the consortium meeting that had been scheduled originally to take place on 2nd and 3rd of April 2020, hosted by CIBER in Madrid.
CARDIATEAM Kick-off Meeting, March 2019
The first CARDIATEAM project meeting took place in March 2019!
This first gathering was an important and exciting milestone: the beginning of our innovative project about diabetic cardiomyopathy.
All the members of our consortium are eager to collaborate and work on an innovative approach to assess whether Type 2 Diabetes has an influence on the development of diabetic cardiomyopathy and if it is unique and distinct from the other types of heart failure.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 821508.
See more on Cordis portal.
The contents of this website and the view expressed in the news and publications are the sole responsibility of the authors and under no circumstances can be regarded as reflecting the position of the European Union.